Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Adicciones (Palma de Mallorca) ; 35(2): 107-118, 2023. tab
Article in English, Spanish | IBECS | ID: ibc-222452

ABSTRACT

El Uso problemático general de Internet (GPIU) supone un uso disfuncionaldel manejo y la gestión de Internet en general. En cambio, el Trastornode juego por Internet (IGD) es una conducta específica vinculada a losvideojuegos en línea. Ambos problemas comienzan a ser frecuentes enadolescentes, pero apenas han sido estudiados simultáneamente ni se conoceel papel conjunto de ambos constructos sobre Calidad de vida relacionadacon la salud (CVRS). El objetivo general de este estudio es analizar larelación entre el GPIU y el IGD y su asociación con la CVRS. El estudioes analítico y transversal con 2024 participantes (46,4% chicos, n = 939)procedentes de 16 colegios en 7 regiones españolas. La media de edad ydesviación típica fue de 14,20±1,42 en un rango de 11-18 años. Se usaronlas versiones españolas del KIDSCREEN-10, del Revised Generalized andProblematic Internet Use Scale 2 y del Internet Gaming Disorder Scale. Un 15,5%del total de la muestra evaluada reportó niveles altos de GPIU y un 3,3%de los jugadores de videojuegos presentó IGD. Las dimensiones del GPIUestán altamente asociadas a las del IGD. La CVRS correlacionó significativay negativamente con todas las dimensiones del GPIU y del IGD (p < ,001).Los participantes que reportaron problemas en el GPIU o el IGD, individualo conjuntamente, presentan puntuaciones significativamente más bajas en la CVRS. (AU)


General Problematic Internet Use (GPIU) is a dysfunctional use of Internethandling and management in general. In contrast, Internet GamingDisorder (IGD) is a specific behaviour linked to online videogames. Bothproblems are becoming common in adolescents, but they have hardly beenstudied simultaneously, and the joint relationship of the two constructs withHealth-Related Quality of Life (HRQoL) is unknown. The general objectiveof this study is to analyse the relationship between GPIU and IGD andtheir association with HRQoL. The study is analytical and cross-sectionalwith 2,024 participants (46.4% boys, n = 939) from 16 schools of 7 Spanishregions. The mean age and standard deviation were 14.20±1.42, with arange of 11-18 years. The Spanish versions of the KIDSCREEN-10, theRevised Generalized and Problematic Internet Use Scale 2 and the InternetGaming Disorder Scale were used. Of the total sample evaluated, 15.5%of the participants had high levels of GPIU, and 3.3% of video gameplayers presented IGD. The dimensions of GPIU are strongly associatedwith those of IGD. HRQoL correlated significantly and negatively withall the dimensions of GPIU and IGD (p <.001). Participants who reportedproblems with GPIU or IGD, individually or conjointly, had significantlylower scores in HRQoL than those with no problems. (AU)


Subject(s)
Humans , Child , Adolescent , Internet , Video Games/psychology , Quality of Life/psychology
2.
Acta Stomatol Croat ; 57(4): 381-394, 2023 Dec.
Article in English | MEDLINE | ID: mdl-38283314

ABSTRACT

Objectives: The aim of this systematic review and meta-analysis is to assess the association between the MIH presence as well as the severity and OHRQoL in children. Material and methods: Relevant studies were identified in PubMed, Embase, Cochrane and Google Scholar. Studies involving MIH and OHRQoL in children were included. A methodological quality assessment of included studies was performed using the Newcastle-Ottawa Scale (NOS) and its adapted version for cross-sectional studies. Random effects models were used to estimate summary effect measures for the association between MIH presence (presence vs. absence) as well as severity (moderate/severe MIH vs. no MIH) and OHRQoL using generic inverse variance meta-analyses. Tests for heterogeneity, publication bias and sensitivity of results were also performed. Results: Out of 1696 identified publications 11 studies reporting on 5,017 children were included in the meta-analysis assessing the impact of MIH presence. There was no statistically significant association between the presence of MIH and lower OHRQoL in affected children (OR = 1.72, 95% CI = 0.99-2.98). Concerning MIH severity and its impact on OHRQoL, a sum of 6 studies were included in the meta-analysis involving a total of 2,595 children. There was a significant association between moderate/severe MIH and lower OHRQoL in affected children (OR = 3.43, 95% CI = 1.69-6.98). Conclusion: Moderate/Severe MIH has a significant and clinically relevant negative impact on OHRQoL, and it should therefore be addressed adequately. Future research should also consider the impact of a uniform MIH diagnosis and precise severity criteria.

3.
West Afr J Med ; 39(10): 1021-1025, 2022 Oct 20.
Article in English | MEDLINE | ID: mdl-36260339

ABSTRACT

BACKGROUND: The Coronavirus disease 2019 (COVID-19) has caused millions of mortalities globally. Although the prevalence and fatality rates of COVID-19 among adolescents is low, its impact on their health-related quality of life (HRQoL) is not adequately known. This study was carried out to determine the burden COVID-19 pandemic has on the HRQoL of adolescents. METHODS: A cross-sectional descriptive study was carried out among adolescents in public and private secondary schools in Jos North Local Government Area of Plateau State. A multistage sampling technique was employed to select the schools and recruit the participants in April/May 2021. Data was collected using a self-administered questionnaire containing the participants' socio-demographic characteristics, questions on being burdened by COVID-19 pandemic, and the KIDSCREEN-10 tool for assessing the HRQoL. The data was analyzed using SPSS version 25.0 and a p-value of < 0.05 was regarded as significant. RESULTS: A total of 405 adolescents participated in the study with a mean age of 14.6 ± 2.06 years. Majority (52.8%) of the participants were girls. More than half (53.3%) of the participants reported being burdened by the COVID-19 pandemic. Also, 45.7% of the participants experienced a lower HRQoL. There was a statistically significant association between being burdened by the COVID-19 pandemic and their HRQoL (χ2 = 7.108, p = 0.01). In addition, the participants' HRQoL was significantly associated with their age (χ2= 5.112, p = 0.02). CONCLUSION: This study highlights the significant burden of COVID-19 pandemic on adolescents' wellbeing. Therefore, there is the need to intensify health intervention strategies among adolescents to reduce the physical, emotional, and mental burden imposed by the COVID-19 pandemic in order to optimize their quality of life.


CONTEXTE: La maladie de coronavirus 2019 (COVID-19) a causé des millions de décès dans le monde. Bien que la prévalence et les taux de mortalité du COVID-19 chez les adolescents soient faibles, son impact sur leur qualité de vie liée à la santé (QVLS) n'est pas suffisamment connu. Cette étude a été menée pour déterminer le poids de la pandémie de COVID-19 sur la QVLS des adolescents. MÉTHODES: Une étude descriptive transversale a été menée parmi les adolescents des écoles secondaires publiques et privées de la région de Jos North Local Government Area de l'Etat du Plateau. Une technique d'échantillonnage à plusieurs degrés a été utilisée pour sélectionner les écoles et recruter les participants en avril/mai 2021. Les données ont été collectées à l'aide d'un questionnaire auto-administré contenant les caractéristiques sociodémographiques des participants, des questions sur le fardeau que représente la pandémie de COVID-19, et l'outil KIDSCREEN-10 pour évaluer la qualité de vie. Les données ont été analysées à l'aide de SPSS version 25.0 et une valeur p < 0,05 a été considérée comme significative. RÉSULTATS: Un total de 405 adolescents ont participé à l'étude avec un âge moyen de 14,6 ± 2,06 ans. La majorité (52,8%) des participants étaient des filles. Plus de la moitié (53,3%) des participants ont déclaré être accablés par la pandémie de COVID-19. En outre, 45,7 % des participants ont connu une baisse de leur qualité de vie. Il y avait une association statistiquement significative entre le fait d'être accablé par la pandémie de COVID-19 et leur QVLS (χ2 = 7,108, p = 0,01). De plus, la QVLS des participants était significativement associée à leur âge (χ2 = 5,112, p = 0,02). CONCLUSION: Cette étude met en évidence le poids important de la pandémie de COVID-19 sur le bien-être des adolescents. Il est donc nécessaire d'intensifier les stratégies d'intervention sanitaire auprès des adolescents pour réduire le fardeau physique, émotionnel et mental imposé par la pandémie de COVID-19 afin d'optimiser leur qualité de vie. Mots clés: Adolescents, École secondaire, COV ID-19, Qualité de vie liée à la santé (QVLS), Jos.


Subject(s)
COVID-19 , Quality of Life , Female , Adolescent , Humans , Child , Male , Quality of Life/psychology , Cross-Sectional Studies , COVID-19/epidemiology , Pandemics , Nigeria/epidemiology , Surveys and Questionnaires , Schools , Students
4.
Trials ; 19(1): 401, 2018 Jul 27.
Article in English | MEDLINE | ID: mdl-30053891

ABSTRACT

BACKGROUND: UK deaths due to chronic liver diseases such as cirrhosis have quadrupled over the last 40 years, making this condition now the third most common cause of premature death. Most patients with advanced cirrhosis (end-stage liver disease [ESLD]) develop ascites. This is often managed with diuretics, but if refractory, then the fluid is drained from the peritoneal cavity every 10-14 days by large volume paracentesis (LVP), a procedure requiring hospital admissions. As the life expectancy of patients with ESLD and refractory ascites (if ineligible for liver transplantation) is on average ≤ 6 months, frequent hospital visits are inappropriate from a palliative perspective. One alternative is long-term abdominal drains (LTADs), used successfully in patients whose ascites is due to malignancy. Although inserted in hospital, these drains allow ascites management outside of a hospital setting. LTADs have not been formally evaluated in patients with refractory ascites due to ESLD. METHODS/DESIGN: Due to uncertainty about appropriate outcome measures and whether patients with ESLD would wish or be able to participate in a study, a feasibility randomised controlled trial (RCT) was designed. Patients were consulted on trial design. We plan to recruit 48 patients with refractory ascites and randomise them (1:1) to either (1) LTAD or (2) current standard of care (LVP) for 12 weeks. Outcomes of interest include acceptability of the LTAD to patients, carers and healthcare professionals as well as recruitment and retention rates. The Integrated Palliative care Outcome Scale, the Short Form Liver Disease Quality of Life questionnaire, the EuroQol 5 dimensions instrument and carer-reported (Zarit Burden Interview) outcomes will also be assessed. Preliminary data on cost-effectiveness will be collected, and patients and healthcare professionals will be interviewed about their experience of the trial with a view to identifying barriers to recruitment. DISCUSSION: LTADs could potentially improve end-of-life care in patients with refractory ascites due to ESLD by improving symptom control, reducing hospital visits and enabling some self-management. Our trial is designed to see if such patients can be recruited, as well as to inform the design of a subsequent definitive trial. TRIAL REGISTRATION: ISRCTN, ISRCTN30697116 . Registered on 7 October 2015.


Subject(s)
Ascites/therapy , Drainage/instrumentation , Drainage/methods , End Stage Liver Disease/therapy , Liver Cirrhosis/therapy , Palliative Care/methods , Adolescent , Adult , Aged , Aged, 80 and over , Ascites/diagnosis , Ascites/etiology , Drainage/adverse effects , End Stage Liver Disease/diagnosis , End Stage Liver Disease/etiology , England , Feasibility Studies , Humans , Liver Cirrhosis/complications , Liver Cirrhosis/diagnosis , Middle Aged , Multicenter Studies as Topic , Quality of Life , Randomized Controlled Trials as Topic , Time Factors , Treatment Outcome , Young Adult
5.
Acta Pharm ; 68(1): 117-125, 2018 Mar 01.
Article in English | MEDLINE | ID: mdl-29453914

ABSTRACT

This study evaluated medication adherence and health-related quality of life (HRQoL) of Slovenian patients with chronic obstructive pulmonary disease (COPD) and examined the factors associated with HRQoL. Demographic and therapy information was collected from 65 patients through interviews. The St. George's Respiratory Questionnaire and the Morisky Medication Adherence Scale were used to evaluate HRQoL and adherence, resp. A multiple linear regression model was used to assess the association between the factors and HRQoL. The mean St. George's Respiratory Questionnaire score (range 0-100, with higher scores indicating lower HRQoL) was 41.4. COPD affected patients' daily activities more than their social and psychological functioning. Slightly more than 53 % of the patients were optimally adherent, while 12 % were non-adherent. Patients with lower HRQoL had a larger number of medications for concomitant diseases, experienced COPD exacerbation in the last year, and had less education. No statistically significant correlation was found between medication adherence and HRQoL.


Subject(s)
Medication Adherence/psychology , Pulmonary Disease, Chronic Obstructive/psychology , Quality of Life/psychology , Activities of Daily Living/psychology , Aged , Cross-Sectional Studies , Female , Humans , Male , Surveys and Questionnaires
6.
Nutr Hosp ; 33(6): 1260-1267, 2016 Nov 29.
Article in English | MEDLINE | ID: mdl-28000451

ABSTRACT

INTRODUCTION: Health-related quality of life (HRQoL) provides a global view of the state of health of a patient receiving home enteral nutrition (HEN). OBJECTIVE: To evaluate the HRQoL of patients receiving HEN using the NutriQoL® questionnaire, a specific instrument regardless of the underlying disease and route of administration. MATERIALS AND METHODS: Observational, prospective and multicentre study conducted in the context of the validation and assessment of the NutriQoL® questionnaire's psychometric properties. RESULTS: One-hundred-and-forty individuals [disease: cancer (58.6%), malabsorption and other (27.1%), neurological (13.6%); HEN: supplement (61.4%), sole source of nutrition (35.7%); administration route: oral (54.3%), ostomy (31.4%), nasoenteric tube (12.1%)] participated. NutriQoL® was reliable [ICC: 0.88 (95%CI: 0.80-0.93); Cronbach's α: 0.77 (1st visit) and 0.83 (2nd visit)], valid (significant Rho), lowly sensitive to changes (effect size 0.23), can be completed by either patients or caregivers (ICC: 0.82). The mean HRQoL (SD) with NutriQoL® was 14.98 (14.86), EQ-5D tariff: 53(0.25), EQ-5D VAS: 54.15 (20.64) and COOP/WONCA charts: 23.32(5.66). HRQoL with NutriQoL® was better (p < 0.05) for oral HEN [19.54 (13,23)], than nasoenteric tube [14(11.71)], ostomy [7.02 (15.48)]; administered orally [19.54 (13.23)], than by gravity [10.97 (14.46)], pump [8.5 (19.78)] or syringe bolus [7 (11.40)]; as a supplement [19.33 (13.73)] instead of sole source of nutrition [8.18 (14.23)]. CONCLUSIONS: NutriQoL® is valid, reliable, even if lowly sensitive to change, and useful to measure HRQoL in this population. More studies are needed to know HRQoL in routine practice.


Subject(s)
Parenteral Nutrition, Home/statistics & numerical data , Quality of Life , Surveys and Questionnaires , Adolescent , Adult , Aged , Female , Health Status Indicators , Humans , Male , Middle Aged , Prospective Studies , Reproducibility of Results , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...